Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Health Insurance

Rx Sales Passed $300 Billion Last Year

Your article was successfully shared with the contacts you provided.

Sales of medications were up 5.1% in 2009, to over $300 billion, from a 2008 growth rate of 1.8%, a market research firm reports.

The arrival of new drugs for cancer, thrombosis and other diseases were a main reason for the increase, according to IMS Health, Norwalk, Conn., which conducted the study. Meanwhile, the arrival of lower-cost generic drugs for epilepsy, migraine, and other disorders helped moderate the rise in costs, IHS said.

Top-selling medication categories in 2009 were antipsychotics, with sales of $14.6 billion, equal to the 2008 level; lipid regulators, with sales of over $13 billion, down 10% from 2008 levels; proton pump inhibitors, $13.6 billion, down 2% year over year; and antidepressants, growing 3% to $9.9 billion.

Generic products now represent 75% of all dispensed prescriptions in the U.S., up from 57% percent in 2004, IMS reported.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.